Novavax eliminates COO role; John Trizzino to depart June 20, 2025

NOVAVAX INC

COO position eliminated; John Trizzino's employment terminated effective June 20, 2025.
Separation pay of $601,778 lump sum plus up to 12 months COBRA premiums.
Consulting agreement June 20 to Dec 31, 2025 at $15,000/month; equity continues vesting during period.
Unvested options from March 2023 grant will fully vest upon consulting agreement termination.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John Trizzino

Chief Operating Officer

NVAX · NOVAVAX INC

Effective: 2025-06-20
Filed: May 27, 2025 23:59 UTC

determined to eliminate the position of Chief Operating Officer, and terminate the employment of John Trizzino with the Company effective as of June 20, 2025.

Source: SEC EDGAR

accession 0001104659-25-052959

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.